找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Drug Discovery and Development; From Targets and Mol Ramarao Poduri Book 2021 Springer Nature Singapore Pte Ltd. 2021 Drug discovery.Pharma

[復制鏈接]
樓主: Covenant
31#
發(fā)表于 2025-3-27 00:32:49 | 只看該作者
32#
發(fā)表于 2025-3-27 01:43:07 | 只看該作者
https://doi.org/10.1007/978-3-7091-8827-9n research and development of stem cells, selecting the source for stem cells, various feasible applications of stem cells, pharmacological bridging with stem cells, preclinical safety evaluation of stem cells, and finally a section on potential applications of stem cells in future.
33#
發(fā)表于 2025-3-27 05:49:49 | 只看該作者
Negative und komplexe Zahlen, Polynome,horough knowledge of the toxicological potential of nanocarriers. Further, the harmonious integration of academia, researcher, industries and regulatory bodies is warranted to ensure the proper regulation of their use.
34#
發(fā)表于 2025-3-27 10:29:33 | 只看該作者
Genetics and Drug Discovery,iew about the mechanisms involved and aim for new drug candidates. Here in this chapter, we discuss the overview of the basic principles involved in genetics, genetic mutations, and related methods engaged in drug discovery.
35#
發(fā)表于 2025-3-27 15:56:09 | 只看該作者
Discovery and Development of Stem Cells for Therapeutic Applications,n research and development of stem cells, selecting the source for stem cells, various feasible applications of stem cells, pharmacological bridging with stem cells, preclinical safety evaluation of stem cells, and finally a section on potential applications of stem cells in future.
36#
發(fā)表于 2025-3-27 20:16:37 | 只看該作者
37#
發(fā)表于 2025-3-27 21:58:16 | 只看該作者
38#
發(fā)表于 2025-3-28 04:00:29 | 只看該作者
39#
發(fā)表于 2025-3-28 06:32:21 | 只看該作者
Clinical Research in Pharmaceutical Drug Development,g proper endpoints, selecting correct study designs, securing quality data, and statistical analyses..As clinical research encompasses a large?part of?drug development, it is difficult to cover?the subject in detail in one chapter; hence we are providing a high-level?overview.
40#
發(fā)表于 2025-3-28 12:49:55 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-14 23:16
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復 返回頂部 返回列表
伊川县| 山东| 会宁县| 桐柏县| 浪卡子县| 台南县| 汉中市| 永德县| 长寿区| 万宁市| 洞口县| 新绛县| 彭山县| 定南县| 湘潭县| 洛浦县| 全南县| 论坛| 衡山县| 澜沧| 兴山县| 平山县| 竹溪县| 金昌市| 西乌| 定西市| 奉化市| 阿坝县| 武安市| 桐庐县| 龙里县| 辽阳县| 汝城县| 隆昌县| 简阳市| 桃园市| 正镶白旗| 中牟县| 扶沟县| 合江县| 克拉玛依市|